🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.710
-0.100 (-5.52%)
At close: Nov 20, 2026, 4:00 PM EST
1.709
-0.001 (-0.06%)
After-hours: Nov 20, 2026, 7:50 PM EST

Company Description

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally.

Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system.

The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names.

It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors.

TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TherapeuticsMD, Inc.
TherapeuticsMD logo
CountryUnited States
Founded2008
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1
CEOMarlan Walker

Contact Details

Address:
951 Yamato Road, Suite 220
Boca Raton, Florida 33431
United States
Phone561 961 1900
Websitetherapeuticsmd.com

Stock Details

Ticker SymbolTXMD
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000025743
CUSIP Number88338N206
ISIN NumberUS88338N2062
Employer ID87-0233535
SIC Code2834

Key Executives

NamePosition
Marlan D. Walker J.D.Chief Executive Officer
Joseph A. ZieglerPrincipal Financial and Accounting Officer

Latest SEC Filings

DateTypeTitle
Nov 20, 2026ARSFiling
Nov 20, 2026DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Nov 20, 2026DEF 14AOther definitive proxy statements
Nov 13, 202610-QQuarterly Report
Nov 13, 20268-KCurrent Report
Aug 11, 202610-QQuarterly Report
Aug 11, 20268-KCurrent Report
Aug 5, 2026SCHEDULE 13G/AFiling
May 12, 202610-QQuarterly Report
May 12, 20268-KCurrent Report
Investor Relations Documents
Annual and quarterly reports, earnings releases, and presentation slides